Abstract
This study identifies state policies authorizing law enforcement access to prescription drug monitoring program data and discusses the characteristics of those policies, particularly in states with laws banning gender-affirming care.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have